During the past decade, Krajska Nemocnice Pardubice Neurologicka Klinika conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Krajska Nemocnice Pardubice Neurologicka Klinika" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Krajska Nemocnice Pardubice Neurologicka Klinika" are "Relapsing Multiple Sclerosis" (3 trials), "Breast Cancer" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials), "Parkinson Disease" (1 trials) and "Parkinson's Disease (Disorder)" (1 trials). Many other conditions were trialed in "Krajska Nemocnice Pardubice Neurologicka Klinika" in a lesser frequency.

Most popular intervention types in "Krajska Nemocnice Pardubice Neurologicka Klinika" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Interferon beta-1a" (2 trials), "Interferon beta-1a-matching placebo" (2 trials), "Ocrelizumab-matching placebo" (2 trials) and "5-Fluorouracil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Krajska Nemocnice Pardubice Neurologicka Klinika" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Krajska Nemocnice Pardubice Neurologicka Klinika". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Krajska Nemocnice Pardubice Neurologicka Klinika, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Krajska Nemocnice Pardubice Neurologicka Klinika, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".